New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase II trial

AIM: To evaluate the efficacy and safety of HL tablet extracted from magnolia officinalis for treating patients with nonalcoholic fatty liver disease (NAFLD). METHODS: Seventy-four patients with NAFLD diagnosed by ultrasonography were randomly assigned to 3 groups given high dose (400 mg) HL tablet,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Jae Yoon, Sohn, Joo Hyun, Baek, Yang Hyun, Cho, Yong Kyun, Kim, Yongsoo, Kim, Hyeonjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Randomized Controlled Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583583/
https://www.ncbi.nlm.nih.gov/pubmed/28932090
http://dx.doi.org/10.3748/wjg.v23.i32.5977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583583/
https://www.ncbi.nlm.nih.gov/pubmed/28932090
http://dx.doi.org/10.3748/wjg.v23.i32.5977

Ejemplares similares